Terms: = Liver cancer AND RPL5, 6125, P46777, MSTP030, MGC117339, ENSG00000122406
8 results:
1. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
Zhang YZ; Zeb A; Cheng LF
Front Immunol; 2022; 13():1032819. PubMed ID: 36439183
[TBL] [Abstract] [Full Text] [Related]
3. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.
Saeki C; Matsuzaki J; Kuroda M; Fujita K; Ichikawa M; Takizawa S; Takano K; Oikawa T; Nakanuma Y; Saruta M; Ochiya T; Tsubota A
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35379653
[TBL] [Abstract] [Full Text] [Related]
4. Low expression of moonlight gene ALAD is correlated with poor prognosis in hepatocellular carcinoma.
Ye Q; Yang X; Zheng S; Mao X; Shao Y; Xuan Z; Huang P
Gene; 2022 May; 825():146437. PubMed ID: 35318110
[TBL] [Abstract] [Full Text] [Related]
5. Colocalization of MID1IP1 and c-Myc is Critically Involved in liver cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
[TBL] [Abstract] [Full Text] [Related]
6. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract] [Full Text] [Related]
7. Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort Study.
Yu SJ; Kim H; Min H; Sohn A; Cho YY; Yoo JJ; Lee DH; Cho EJ; Lee JH; Gim J; Park T; Kim YJ; Kim CY; Yoon JH; Kim Y
J Proteome Res; 2017 Mar; 16(3):1239-1248. PubMed ID: 28112944
[TBL] [Abstract] [Full Text] [Related]
8. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract] [Full Text] [Related]
